Month: June 2024

Image Credit: Adobe Stock Images/GraphicRoyalty.com Estrogen receptor–positive (ER+) breast cancer—which is when cancer cells with receptors attach to estrogen—make up more than 70% of all breast cancer diagnoses. Receptors must be found in more than 10% of cancers in order to be considered ER.+ To combat this, the use of endocrine therapy, along with the […]

The creation of the electronic common technical document (eCTD) revolutionized the pharmaceutical regulatory submission process. It enabled the phasing out of paper-based processes, bringing much needed speed, reliability, and efficiency to global regulatory submissions. As the standard format for submitting regulatory applications, supplements, and amendments, eCTD is accepted by health authorities around the world, such […]

A digital rendering of the south facade of Kyowa Kirin’s manufacturing facility. Image Credit: Kyowa Kirin Kyowa Kirin, Inc., a global specialty pharmaceutical company and affiliate of Kyowa Kirin Co., Ltd, will be financially committing up to $530 million for the construction of a new, state-of-the-art manufacturing facility in Sanford, NC.1 With construction expected to begin in the […]

Image Credit: Adobe Stock Images/Wladimir1804.com When it comes to the older adult demographic, there is an association between social service investments—such as income support, nutrition assistance, and housing support—and a decrease in medical care costs and improvements in health. As noted by the authors of a study published in JAMA Network Open,1 medical investments have […]

Pharmaceutical Commerce – June 2024 Issue (PDF) ‘Maturity’ Matters: Fortifying Two Key Cogs of Pharma Supply Chain Dynamic Pricing: What Pharma Needs? Combining RWE and AI to Bend the Adherence Curve Justifying Price Fairness How Serious Are You About Patient Centricity? Medicine for the Planet: Building a Sustainable Legacy in Pharma Supply Chains The Need […]

Mark Cuban Talks Drug Pricing Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur, in an interview with Pharm Exec, discusses the prescription drug cost landscape and shares his recipe for true disruption to the pharma pricing machine. Cost Remains Significant Barrier to Respiratory Care for Patients […]

PC: Could you describe some common pain points in the space that the industry has been experiencing? Cheng: I will build off of what I just mentioned. If you think about patient access, if you think about the regulatory requirements, if you think about market access as it relates to pricing and reimbursement, one of […]

Image Credit: Adobe Stock Images/Iryna.com If the COVID-19 pandemic could be boiled down to one lesson, it is the fact that vaccines played an effective role in limiting the spread of infectious disease. Sure, supply chain issues that impact manufacturing and distribution efforts can occur—alongside length regulatory approval processes—but no process is flawless. Interestingly enough, […]

Rising cost pressures demand more efficient operations. Micro-launches are creating shorter go-to-market runways. The continued rise of specialty drugs with small patient populations puts increased pressure on companies’ promotional efforts. In this landscape, there are many ideas for how to improve commercial focus and effectiveness. However, maximizing the impact of commercial efforts starts with putting […]

Global price comparisons for prescription drugs continue to draw the attention of politicians, medical groups, and patient organizations. WHO and lower-income countries advocate for income-based pricing to address their low levels of affordability. However, higher-income countries systematically use lower prices around the world to lower their prices through international price referencing. Is the US subsidizing […]

It’s widely understood that poor adherence to prescribed medication regimens has far-reaching clinical and cost implications for all healthcare stakeholders. For example, patients who never start or don’t stay on prescribed treatments fail to control their symptoms and often experience disease progression and increased morbidity and mortality. Insurance companies end up paying for expensive medical […]

Image Credit: Adobe Stock Images/JK_kyota.com Inizio Engage, a strategic, commercial, and creative engagement partner that specializes in healthcare, is launching a new global experiential agency, Emota, thereby combining Ashfield Event Experiences (AEE) and WRG.1 The resulting agency is expected to provide a full portfolio of services and capabilities that serve the healthcare industry and global […]

As the benchmark of a successful business, sustainability and being environmentally focused is more than a symbol of advancement and efficiency; it is an absolute necessity for a world facing growing ecological concerns. Modern organizations must remain cognizant of their inefficiencies and their peripheral effects on our planet. To bring sustainability to the forefront, environmental, […]

Image credit: Cagkan | stock.adobe.com The 340B Drug Pricing Program continued to evolve in 2023, and further changes may be forthcoming as a result of ongoing lawsuits and regulatory action. For years, the program has become increasingly controversial, due to a lack of consensus between covered entities1 and pharmaceutical manufacturers over the permissible scope of […]

Image Credit: Bionova Scientific Bionova Scientific, a biologics contract development and manufacturing organization (CDMO) that was acquired by Asahi Kasei Medical,is dipping its toes into plasmid DNA (pDNA) production.1 This endeavor will be centered around a new development and manufacturing facility in The Woodlands, TX, which is close to Houston. Once the plant becomes operational […]